(Q41370342)

30 September 2017

title

COOH-terminal substitutions in the serpin C1 inhibitor that cause loop overinsertion and subsequent multimerization (English)

1 reference

30 September 2017

Eldering E

1

1 reference

30 September 2017

Verpy E

2

1 reference

30 September 2017

Roem D

3

1 reference

30 September 2017

Meo T

4

1 reference

30 September 2017

Tosi M

5

1 reference

30 September 2017

language of work or name

English

0 references

publication date

1 February 1995

1 reference

Journal of Biological Chemistry

30 September 2017

number of pages

9

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

30 September 2017

volume

270

1 reference

30 September 2017

issue

6

1 reference

30 September 2017

page(s)

2579-2587

1 reference

Human plasma proteinase inhibitors

30 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.6.2579

Structural aspects of serpin inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.6.2579

On the size of the active site in proteases. I. Papain

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.6.2579

Plakalbumin, alpha 1-antitrypsin, antithrombin and the mechanism of inflammatory thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.6.2579

Human alpha 1-proteinase inhibitor. Crystal structure analysis of two crystal modifications, molecular model and preliminary analysis of the implications for function

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.6.2579

Human plasma kallikrein and C1 inhibitor form a complex possessing an epitope that is not detectable on the parent molecules: demonstration using a monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.6.2579

Implications of the three-dimensional structure of alpha 1-antitrypsin for structure and function of serpins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.6.2579

Ovalbumin and angiotensinogen lack serpin S-R conformational change

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.6.2579

Antithrombin Vicenza, Ala 384 to Pro (GCA to CCA) mutation, transforming the inhibitor into a substrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.6.2579

C1 inhibitor hinge region mutations produce dysfunction by different mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.6.2579

Alpha 1-proteinase inhibitor variant T345R. Influence of P14 residue on substrate and inhibitory pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.6.2579

Effects of mutations in the hinge region of serpins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.6.2579

The structural basis for neutrophil inactivation of C1 inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.6.2579

The mechanism of Z alpha 1-antitrypsin accumulation in the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.6.2579

Serpin tertiary structure transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.6.2579

Antithrombin III Utah: proline-407 to leucine mutation in a highly conserved region near the inhibitor reactive site

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.6.2579

Pleiotropic effects of antithrombin strand 1C substitution mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.6.2579

High efficiency polyoma DNA transfection of chloroquine treated cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.6.2579

Proteolytic inactivation of plasma C1- inhibitor in sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.6.2579

Biological implications of a 3 A structure of dimeric antithrombin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.6.2579

Structural transition of alpha 1-antitrypsin by a peptide sequentially similar to beta-strand s4A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.6.2579

Size and shape of human C1-inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.6.2579

Studies on human plasma C1 inactivator-enzyme interactions. I. Mechanisms of interaction with C1s, plasmin, and trypsin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.6.2579

Rapid and sensitive techniques for identification and analysis of 'reactive-centre' mutants of C1-inhibitor proteins contained in type II hereditary angio-oedema plasmas

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.6.2579

HEREDITARY ANGIONEUROTIC EDEMA: TWO GENETIC VARIANTS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.6.2579

C1 inhibitor and hereditary angioneurotic edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.6.2579

Plasma levels of C1- inhibitor complexes and cleaved C1- inhibitor in patients with hereditary angioneurotic edema.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.6.2579

Alpha 1-antitrypsin deficiency, emphysema, and liver disease. Genetic basis and strategies for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.6.2579

Protein folding in the cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.6.2579

The intact and cleaved human antithrombin III complex as a model for serpin-proteinase interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.6.2579

Structural basis of latency in plasminogen activator inhibitor-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.6.2579

Mobile reactive centre of serpins and the control of thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.6.2579

Immunologic evidence for insertion of the reactive-bond loop of antithrombin into the A beta-sheet of the inhibitor during trapping of target proteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.6.2579

Mechanism of serpin action: evidence that C1 inhibitor functions as a suicide substrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.6.2579

Antithrombin Cambridge II, 384 Ala to Ser. Further evidence of the role of the reactive centre loop in the inhibitory function of the serpins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.6.2579

Conformation of the reactive site loop of alpha 1-proteinase inhibitor probed by limited proteolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.6.2579

Effect of the Z mutation on the physical and inhibitory properties of alpha 1-antitrypsin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.6.2579

A Pro----Leu substitution in codon 369 of the alpha-1-antitrypsin deficiency variant PI MHeerlen

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.6.2579

Two-domain structure of the native and reactive centre cleaved forms of C1 inhibitor of human complement by neutron scattering

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.6.2579

Conformational change in antithrombin induced by heparin probed with a monoclonal antibody against the 1C/4B region

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.6.2579

21 January 2018

Identifiers

DOI

10.1074/JBC.270.6.2579

1 reference

30 September 2017

1 reference